Michael D. Davis

5.2k total citations · 1 hit paper
100 papers, 3.9k citations indexed

About

Michael D. Davis is a scholar working on Molecular Biology, Physiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Michael D. Davis has authored 100 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 25 papers in Physiology and 22 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Michael D. Davis's work include Metabolism and Genetic Disorders (21 papers), Asthma and respiratory diseases (13 papers) and Sphingolipid Metabolism and Signaling (12 papers). Michael D. Davis is often cited by papers focused on Metabolism and Genetic Disorders (21 papers), Asthma and respiratory diseases (13 papers) and Sphingolipid Metabolism and Signaling (12 papers). Michael D. Davis collaborates with scholars based in United States, United Kingdom and Canada. Michael D. Davis's co-authors include Kevin R. Lynch, Seymour Kaufman, Timothy L. Macdonald, Jeremy J. Clemens, Markus Zollinger, Robert Hof, Eva E. Prieschl, Rainer Albert, Carolyn A. Foster and Volker Brinkmann and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Michael D. Davis

91 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Immune Modulator FTY720 Targets Sphingosine 1-Phosphate Receptors

2002 1.2k citations Volker Brinkmann, Michael D. Davis et al. Journal of Biological Chemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael D. Davis United States	31	2.3k	559	530	518	301	100	3.9k
Juan Carlos Vera United States	44	2.4k 1.0×	715 1.3×	405 0.8×	415 0.8×	221 0.7×	133	6.1k
Kenichi Tanaka Japan	42	2.6k 1.1×	474 0.8×	649 1.2×	334 0.6×	168 0.6×	243	6.1k
Osamu Inanami Japan	34	1.9k 0.8×	612 1.1×	602 1.1×	283 0.5×	68 0.2×	182	4.2k
Ghassan J. Maghzal Australia	35	1.6k 0.7×	915 1.6×	681 1.3×	224 0.4×	124 0.4×	57	3.7k
Arnold Stern United States	34	1.8k 0.8×	807 1.4×	335 0.6×	285 0.6×	89 0.3×	115	3.8k
John P. MacManus Canada	45	3.9k 1.7×	469 0.8×	344 0.6×	701 1.4×	120 0.4×	127	6.3k
Giovambattista Pani Italy	41	3.1k 1.3×	1.0k 1.9×	1.4k 2.6×	372 0.7×	124 0.4×	96	5.8k
Ronald J. Koenig United States	44	3.0k 1.3×	589 1.1×	318 0.6×	392 0.8×	302 1.0×	123	7.1k
Ryuichi Kato Japan	49	4.3k 1.9×	677 1.2×	974 1.8×	1.1k 2.1×	161 0.5×	272	7.8k

Countries citing papers authored by Michael D. Davis

Since Specialization

Citations

This map shows the geographic impact of Michael D. Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael D. Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael D. Davis more than expected).

Fields of papers citing papers by Michael D. Davis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael D. Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael D. Davis. The network helps show where Michael D. Davis may publish in the future.

Co-authorship network of co-authors of Michael D. Davis

This figure shows the co-authorship network connecting the top 25 collaborators of Michael D. Davis. A scholar is included among the top collaborators of Michael D. Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael D. Davis. Michael D. Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gaston, Benjamin, Laura Smith, Michael D. Davis, et al.. (2024). Antigen stasis and airway nitrosative stress in human primary ciliary dyskinesia. American Journal of Physiology-Lung Cellular and Molecular Physiology. 326(4). L468–L476. 3 indexed citations

Davis, Michael D.. (2024). 2023 Year in Review: High-Flow Nasal Cannula for COVID-19. Respiratory Care. 69(12). 1587–1591.

Wang, Ran & Michael D. Davis. (2024). A Concise Review of Exhaled Breath Testing for Respiratory Clinicians and Researchers. Respiratory Care. 69(5). 613–620. 6 indexed citations

Davis, Michael D., et al.. (2024). Plastic bronchitis in an adult. SHILAP Revista de lepidopterología. 12(11). e70063–e70063.

Davis, Michael D., et al.. (2023). Desalkylgidazepam blood concentrations in 63 forensic investigation cases. Journal of Analytical Toxicology. 47(9). 858–866. 3 indexed citations

Davis, Michael D., et al.. (2023). Methods to Detect Volatile Organic Compounds for Breath Biopsy Using Solid-Phase Microextraction and Gas Chromatography–Mass Spectrometry. Molecules. 28(11). 4533–4533. 18 indexed citations

Davis, Michael D., et al.. (2023). Nocturnal High-Flow Nasal Cannula Therapy and Sinonasal Symptoms During Cystic Fibrosis Exacerbations. Respiratory Care. 68(11). 1527–1531.

Relich, Ryan F., et al.. (2023). Effects of pH alteration on respiratory syncytial virus in human airway epithelial cells. ERJ Open Research. 9(4). 404–2022. 1 indexed citations

Davis, Michael D., et al.. (2021). 2020 Year in Review: Pharmacologic Treatments for COVID-19. Respiratory Care. 66(7). 1167–1172. 2 indexed citations

10.

Kuch, Bradley A., et al.. (2020). Local Effects of Two Intravenous Formulations of Pulmonary Vasodilators on Airway Epithelium. Respiratory Care. 65(10). 1427–1432. 1 indexed citations

11.

Davis, Michael D., Olivia Giddings, Kristie Ross, et al.. (2020). A Treatment to Eliminate SARS-CoV-2 Replication in Human Airway Epithelial Cells Is Safe for Inhalation as an Aerosol in Healthy Human Subjects. Respiratory Care. 66(1). 113–119. 3 indexed citations

12.

Davis, Michael D., et al.. (2013). AARC Clinical Practice Guideline: Blood Gas Analysis and Hemoximetry: 2013. Respiratory Care. 58(10). 1694–1703. 85 indexed citations

13.

Davis, Michael D., Alison Montpetit, & J.F. Hunt. (2012). Exhaled Breath Condensate. Immunology and Allergy Clinics of North America. 32(3). 363–375. 76 indexed citations

14.

Park, Chung, Il‐Young Hwang, Rajesh Kumar Sinha, et al.. (2011). Lymph node B lymphocyte trafficking is constrained by anatomy and highly dependent upon chemoattractant desensitization. Blood. 119(4). 978–989. 48 indexed citations

15.

Foss, Frank W., Thomas P. Mathews, Yugesh Kharel, et al.. (2009). Synthesis and biological evaluation of sphingosine kinase substrates as sphingosine-1-phosphate receptor prodrugs. Bioorganic & Medicinal Chemistry. 17(16). 6123–6136. 27 indexed citations

16.

Foss, Frank W., Jeremy J. Clemens, Michael D. Davis, et al.. (2005). Synthesis, stability, and implications of phosphothioate agonists of sphingosine-1-phosphate receptors. Bioorganic & Medicinal Chemistry Letters. 15(20). 4470–4474. 21 indexed citations

17.

Davis, Michael D., Jeremy J. Clemens, Timothy L. Macdonald, & Kevin R. Lynch. (2004). Sphingosine 1-Phosphate Analogs as Receptor Antagonists. Journal of Biological Chemistry. 280(11). 9833–9841. 235 indexed citations

18.

Brinkmann, Volker, Michael D. Davis, Christopher E. Heise, et al.. (2002). The Immune Modulator FTY720 Targets Sphingosine 1-Phosphate Receptors. Journal of Biological Chemistry. 277(24). 21453–21457. 1246 indexed citations breakdown →

19.

Davis, Michael D. & Seymour Kaufman. (1991). 7‐Tetrahydrobiopterin is an uncoupled cofactor for rat hepatic phenylalanine hydroxylase. FEBS Letters. 285(1). 17–20. 22 indexed citations

20.

Celikel, Reha, et al.. (1991). Crystallization and preliminary X-ray analysis of phenylalanine hydroxylase from rat liver. Journal of Molecular Biology. 218(3). 495–498. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact